Adverts

Open Access Articles- Top Results for Emibetuzumab

Emibetuzumab

</th></tr>
Emibetuzumab?
Monoclonal antibody
Source Humanized (from mouse)
Target HGFR
Clinical data
Identifiers
1365287-97-3
None
Chemical data
Formula C6356H9810N1694O2014S48
143.7 kDa

Emibetuzumab[1] is a monoclonal antibody designed for the treatment of cancer.[2]

This drug was developed by Eli Lilly & Company.

References

  1. ^ World Health Organization (2014). "International Nonproprietary Names for Pharmaceutical Substances (INN). Proposed INN: List 111" (PDF). WHO Drug Information 28 (2). 
  2. ^ Statement On A Nonproprietary Name Adopted By The USAN Council - Emibetuzumab, American Medical Association.

Lua error in package.lua at line 80: module 'Module:Buffer' not found.